Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emmessar Biotech & Nutrition held a board meeting on August 7, 2025, with three key outcomes. First, the company submitted its unaudited financial results for the quarter ended June 30, 2025, which were reviewed by statutory auditor V Nagarajan & Co. The auditor issued an unmodified (clean) limited review report, confirming nothing came to their attention suggesting the results were not prepared in accordance with applicable accounting standards. Second, the Annual General Meeting has been scheduled for Friday, September 26, 2025, at 10:30 a.m., to be conducted via video conferencing in line with MCA and SEBI circulars. Third, the company has arranged e-voting facilities through MUFG Intime India, with the remote e-voting window running from September 23 to September 25, 2025, and a cut-off date of September 19, 2025.
This is a routine regulatory compliance filing with no material negative news. The clean auditor review and orderly AGM/e-voting arrangements signal normal governance, with no impact expected on share price from this announcement.